chronic active b-cell-receptor signalling diffuse large b-cell lymphoma
role b-cell-receptor bcr signalling lymphomagenesis inferred studying immunoglobulin genes human lymphomas engineering mouse models genetic functional evidence oncogenic role human lymphomas needed describe form chronic active bcr signalling required cell survival activated b-cell-like abc subtype diffuse large b-cell lymphoma dlbcl signalling adaptor card11 required constitutive nf-kappa b pathway activity survival abc dlbcl4 roughly % abc dlbcls mutant card11 isoforms activate nf-kappa b- mechanism engages wild-type card11 abc dlbcls unknown rna interference genetic screen revealed bcr signalling component brutons tyrosine kinase essential survival abc dlbcls wild-type card11 addition knockdown proximal bcr subunits igm ig-kappa cd79a cd79b killed abc dlbcls wildtype card11 lymphomas bcrs abc dlbcls formed prominent clusters plasma membrane low diffusion similarly bcrs antigen-stimulated normal b cells somatic mutations affecting immunoreceptor tyrosine-based activation motif itam signalling modules cd79b cd79a detected frequently abc dlbcl biopsy samples rarely dlbcls never burkitts lymphoma mucosa-associated lymphoid tissue lymphoma % abc dlbcls one functionally critical residue cd79b first itam tyrosine mutated mutations increased surface bcr expression attenuated lyn kinase feedback inhibitor bcr signalling findings establish chronic active bcr signalling new pathogenetic mechanism abc dlbcl suggesting several therapeutic strategies
